Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Ali Mohammed A. Alasmari"'
Autor:
Mohannad Abdulrazzaq Alalwan, Ibrahim Ali I. Alasseri, Abdullah Obaid Binobaid, Adel Mushref Ali Alharban, Bashayer Ateya Al-Harthy, Nareman Suliman Shamlan, Fatema Salman Hasan Salman Khalaf, Ali Mohammed A. Alasmari, Balgaith H. Albareqi, Kawther Abdulroof Alabbas, Yousef Mohammed Alhazmi, Meryem Safi, Haider Issa Alaqaili, Maan Ahmed Alsaaid
Publikováno v:
The Egyptian Journal of Hospital Medicine. 69:2455-2458
Anticoagulation is the mainstay treatment of pulmonary embolism. Using low molecular weight heparin versus unfractionated heparin remains a matter of debate. Objectives: the aim of this review is to study the prognosis of using low molecular weight v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d0e975d8337de3f704a1259d3a2ef1b5
https://doi.org/10.12816/0041693
https://doi.org/10.12816/0041693
Autor:
Mouad Mohammed alqadi, Meshal Mohammed Abdullah Albaqami, Ali Mohammed A. Alasmari, Mohannad Sami Felemban, Mohammed Aiman Halawani, Haneen Saud Alsufyani, Wael Hamed Alsaedi, Jameel Abdullah Awadain, Wahhaj Abdullah Rawas, Sufyan Saud Alsufyani, Nebras Faisal Alsaadi
Publikováno v:
The Egyptian Journal of Hospital Medicine. 67:599-604
Background: Alopecia areata (AA) is one of the most common autoimmune disorders and its severe types are resistant to almost all conventional therapies. Methotrexate (MTX) has been used as an adjunctive therapy in some autoimmune disorders and has be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5f11ee67d4d74e12ac1c9d1175a95f9e
https://doi.org/10.12816/0037811
https://doi.org/10.12816/0037811